What is the Future of Health Economics Assessment of Drugs in France?

This article provides an in-depth description of the France’s CEESP structure and working methods, and analyses the impact of health economic assessment on market access of drugs in France, as well as pointing out the areas of uncertainty and the conflicting rules following the introduction of the health economic assessment. Learn more here. (Source: Journal of Market Access & Health Policy, 2015)

You might also be interested in:

How HEOR Professionals Can Be Force Multipliers in the Fight… 10/06/2020
Robert Dubois, MD, PhD, Steps in as Interim President and CEO… 09/01/2020
Tufts Analyzes Cost-Effectiveness Analysis for 1974-2018 07/28/2020
Addressing the Affordability Crisis of Cell & Gene Therapies 12/16/2020
Key Innovations Coming From The Next Generation of PBM’s 08/12/2020
[Webinar] How can VA/HTA Inform Policy Interventions and… 10/15/2020
Employee Health Data Analyses Must Include Race And Ethnicity 12/28/2020